Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 1:09 pm Sale | 2023-12-31 | 13G | KALA BIO, Inc. KALA | Checkpoint Capital L.P. | 0 0.000% | -228,032 (Position Closed) | Filing History |
| 2024-01-29 4:36 pm Sale | 2023-12-31 | 13G | KALA BIO, Inc. KALA | Integrated Core Strategies (US) LLC | 132,674 4.900% | -1,029 (-0.77%) | Filing History |
| 2023-10-18 4:04 pm Unchanged | 2023-05-01 | 13D | KALA BIO, Inc. KALA | Longitude Capital Partners II LLC | 108,239 4.300% | 0 (Unchanged) | Filing History |
| 2023-06-15 11:57 am Purchase | 2023-06-05 | 13G | KALA BIO, Inc. KALA | Checkpoint Capital L.P. | 228,032 9.700% | 228,032 (New Position) | Filing History |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13D | KALA BIO, Inc. KALA | Longitude Capital Partners II LLC | 108,239 6.300% | -110,042 (-50.41%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KALA BIO, Inc. KALA | Baker Bros. Advisors LP | 180,913 9.990% | 180,913 (New Position) | Filing History |
| 2023-01-17 4:38 pm Purchase | 2023-01-04 | 13G | KALA BIO, Inc. KALA | Integrated Core Strategies (US) LLC | 133,703 8.400% | 133,703 (New Position) | Filing History |
| 2022-06-03 5:11 pm Sale | 2022-06-02 | 13D | KALA BIO, Inc. KALA | RA Capital Management, L.P. | 136,515 4.700% | -111,277 (-44.91%) | Filing History |
| 2022-05-31 5:31 pm Sale | 2022-05-26 | 13D | KALA BIO, Inc. KALA | RA Capital Management, L.P. | 247,792 8.530% | -74,020 (-23.00%) | Filing History |
| 2022-05-25 5:12 pm Sale | 2022-05-23 | 13D | KALA BIO, Inc. KALA | RA Capital Management, L.P. | 321,812 11.080% | -114,773 (-26.29%) | Filing History |
| 2022-04-01 4:30 pm Sale | 2022-03-30 | 13D | KALA BIO, Inc. KALA | RA Capital Management, L.P. | 436,585 15.030% | -1,877 (-0.43%) | Filing History |
| 2022-02-14 11:50 am Sale | 2021-12-31 | 13G | KALA BIO, Inc. KALA | Eventide Asset Management, LLC | 0 0.000% | -138,000 (Position Closed) | Filing History |
| 2022-01-10 12:54 pm Sale | 2021-12-31 | 13G | KALA BIO, Inc. KALA | BlackRock Inc. BLK | 125,391 4.800% | -1,029 (-0.81%) | Filing History |
| 2021-11-26 4:17 pm Purchase | 2021-11-15 | 13D | KALA BIO, Inc. KALA | Lagunita LLC | 213,645 7.300% | 213,645 (New Position) | Filing History |
| 2021-11-26 4:16 pm Purchase | 2021-11-15 | 13D | KALA BIO, Inc. KALA | Lagunita Biosciences LLC | 213,645 7.300% | 213,645 (New Position) | Filing History |
| 2021-11-24 2:27 pm Purchase | 2021-11-15 | 13D | KALA BIO, Inc. KALA | Blumenkranz Mark S. | 213,645 7.300% | 213,645 (New Position) | Filing History |
| 2021-10-28 4:23 pm Purchase | 2009-02-28 | 13D | KALA BIO, Inc. KALA | RA Capital Management, L.P. | 438,461 16.850% | 3,477 (+0.80%) | Filing History |
| 2021-10-14 5:00 pm Sale | 2021-10-12 | 13G | KALA BIO, Inc. KALA | ORBIMED ADVISORS LLC | 0 0.000% | -188,568 (Position Closed) | Filing History |
| 2021-03-01 6:09 pm Unchanged | 2020-12-31 | 13G | KALA BIO, Inc. KALA | ORBIMED ADVISORS LLC | 188,568 8.410% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:53 pm Purchase | 2020-12-31 | 13G | KALA BIO, Inc. KALA | ORBIMED ADVISORS LLC | 188,568 8.410% | 50,654 (+36.73%) | Filing History |